S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
His system isolated NVIDIA - Here's His Next Buy. (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software" (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Why The Likes Of Tesla, Toyota, Are The Winners From UAW Strikes
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
His system isolated NVIDIA - Here's His Next Buy. (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software" (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Why The Likes Of Tesla, Toyota, Are The Winners From UAW Strikes
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
His system isolated NVIDIA - Here's His Next Buy. (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software" (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Why The Likes Of Tesla, Toyota, Are The Winners From UAW Strikes
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
His system isolated NVIDIA - Here's His Next Buy. (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
The Next Stage Of Google’s Rally Just Started
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Can Investors Win the Race with Dividend Achiever Nike?
CarMax Slides On Earnings Disappointment, Time To Celebrate?
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software" (Ad)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Why The Likes Of Tesla, Toyota, Are The Winners From UAW Strikes
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Forecast, Price & News

$10.12
+0.46 (+4.76%)
(As of 09/29/2023 ET)
Compare
Today's Range
$9.66
$10.14
50-Day Range
$9.35
$14.32
52-Week Range
$6.40
$15.87
Volume
812,629 shs
Average Volume
369,554 shs
Market Capitalization
$576.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.55

Health Catalyst MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
43.7% Upside
$14.55 Price Target
Short Interest
Healthy
1.79% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
0.78mentions of Health Catalyst in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$73,600 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.93) to ($0.85) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.40 out of 5 stars

Medical Sector

249th out of 971 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

20th out of 61 stocks


HCAT stock logo

About Health Catalyst (NASDAQ:HCAT) Stock

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

HCAT Price History

HCAT Stock News Headlines

This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Experts: NVIDIA Now "Too Big to Succeed"
Several of the market’s top analysts are sounding the alarm that NVIDIA’s share price may have reached its breaking point.
Health Catalyst Reports Second Quarter 2023 Results
Steven Cohen Boosts Stake in Health Catalyst Inc
RBC Capital Sticks to Its Hold Rating for Health Catalyst (HCAT)
Health Catalyst (HCAT) Gets a Buy from Wells Fargo
Health Catalyst: Recovery Won't Be Soon
See More Headlines
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

HCAT Company Calendar

Last Earnings
8/08/2023
Today
9/30/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HCAT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$14.55
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+43.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

Net Income
$-137,400,000.00
Pretax Margin
-51.63%

Debt

Sales & Book Value

Annual Sales
$284.60 million
Book Value
$7.76 per share

Miscellaneous

Free Float
55,425,000
Market Cap
$576.47 million
Optionable
Not Optionable
Beta
1.30
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Daniel D. BurtonMr. Daniel D. Burton (Age 48)
    CEO & Director
    Comp: $158.9k
  • Mr. Bryan Truman Hunt (Age 36)
    Chief Financial Officer
    Comp: $370.46k
  • Mr. Daniel H. OrensteinMr. Daniel H. Orenstein (Age 53)
    Sr. Advisor
    Comp: $356.56k
  • Mr. Kevin Freeman (Age 50)
    Chief Commercial Officer
    Comp: $405.9k
  • Ms. Anne Marie Bickmore (Age 60)
    COO & Chief Product Officer
  • Mr. Jason  AlgerMr. Jason Alger (Age 39)
    Chief Accounting Officer
  • Mr. Dave Ross
    Chief Technology Officer
  • Mr. Adam Brown
    Sr. VP of Investor Relations and Financial Planning & Analysis
  • Mr. Benjamin Landry
    Gen. Counsel & Sec. of the Board
  • Ms. Tarah Neujahr Bryan
    Chief Marketing & Communications Officer













HCAT Stock - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings
or view top-rated stocks.

What is Health Catalyst's stock price forecast for 2023?

9 equities research analysts have issued 12 month price targets for Health Catalyst's shares. Their HCAT share price forecasts range from $8.00 to $18.00. On average, they expect the company's stock price to reach $14.55 in the next year. This suggests a possible upside of 43.7% from the stock's current price.
View analysts price targets for HCAT
or view top-rated stocks among Wall Street analysts.

How have HCAT shares performed in 2023?

Health Catalyst's stock was trading at $10.63 at the beginning of the year. Since then, HCAT stock has decreased by 4.8% and is now trading at $10.12.
View the best growth stocks for 2023 here
.

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our HCAT earnings forecast
.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) issued its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.09. The firm earned $73.21 million during the quarter, compared to analyst estimates of $72.67 million. Health Catalyst had a negative net margin of 51.76% and a negative trailing twelve-month return on equity of 16.49%.

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst issued an update on its third quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $70.20 million-$74.20 million, compared to the consensus revenue estimate of $72.86 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).

When did Health Catalyst IPO?

(HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

What is Health Catalyst's stock symbol?

Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT."

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Health Catalyst's stock price today?

One share of HCAT stock can currently be purchased for approximately $10.12.

How much money does Health Catalyst make?

Health Catalyst (NASDAQ:HCAT) has a market capitalization of $576.47 million and generates $284.60 million in revenue each year. The company earns $-137,400,000.00 in net income (profit) each year or ($2.68) on an earnings per share basis.

How many employees does Health Catalyst have?

The company employs 1,200 workers across the globe.

How can I contact Health Catalyst?

Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The official website for the company is www.healthcatalyst.com. The company can be reached via phone at (801) 708-6800 or via email at ir@healthcatalyst.com.

This page (NASDAQ:HCAT) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -